| For Practicing Oncologists |
  See all
 | Articles: Myeloproliferative Dz |
Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens
Leukemia and Lymphoma, 05/16/08
Myelodysplastic syndromes
Blood, 05/15/08
BH3-only proteins Noxa, Bmf, and Bim are necessary for arsenic trioxide–induced cell death in myeloma
Blood, 05/14/08
Multiple myeloma cells directly stimulate bone resorption in vitro by down-regulating mature osteoclast apoptosis
Leukemia Research, 05/12/08
Current status of epigenetic treatment in myelodysplastic syndromes
Annals of Hematology, 05/09/08
Cytogenetic features in myelodysplastic syndromes
Annals of Hematology, 05/09/08
CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma
Clinical Cancer Research, 05/06/08
Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110–FGFR1 fusion
Leukemia Research, 05/06/08
Phase II clinical trial of arsenic trioxide with liposomal doxorubicin, vincristine, and dexamethasone in newly diagnosed multiple myeloma
Leukemia Research, 05/06/08
Multicenter, randomized, double-blind, placebo-controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myeloma
Journal of Clinical Oncology, 05/01/08
|
|
Receive daily email updates on Myeloproliferative Dz
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
228 Available Pages
|
 |
| Sponsor |
|
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
 |
| Sponsor |
|
|
| Sponsor |
|
|
| Sponsor |
|
